Ketamine cystitis as a mimic of carcinoma in situ

Histopathology

Volumn 55, Issue 6, 2009, Pages 705-708

  Oxley, Jon D ^a   Cottrell, Angela M ^a   Adams, Susan ^b   Gillatt, David ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b YEOVIL DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Bladder; Carcinoma in situ; Ketamine

Indexed keywords

CYTOKERATIN 20; KETAMINE; KI 67 ANTIGEN;

ADULT; ARTICLE; BLADDER BIOPSY; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; ULCER;

ADULT; CARCINOMA; CYSTITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KETAMINE; MALE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 70849124338     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03437.x     Document Type: Article

References (10)

1. McCambridge J, Winstock A, Hunt N, Mitcheson L. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. Eur. Addict. Res. 2007 13 57 64.
2. McNicoll A, DrugScope Press Office. Drugscope highlights concerns over trends in ketamine use (2009). Available at http://www.drugscope.org.uk/ Last accessed 6 November 2009.
3. Chu PS, Ma WK, Wong SC et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int. 2008 102 1616 1622.
4. Shahani R, Streutker C, Dickson B, Stewart RJ. Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 2007 69 810 812.
5. Colebunders B, Van Erps P. Cystitis due to the use of ketamine as a recreational drug: a case report. J. Med. Case Reports 2008 2 219.
6. Cottrell AM, Gillatt D. Ketamine associated urinary tract pathology: the tip of the iceberg for urologists? Br. J. Med. Surg. Urol. 2008 1 136 138.
7. Milord RA, Lecksell K, Epstein JI. An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ. Hum. Pathol. 2001 32 997 1002.
8. McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am. J. Surg. Pathol. 2001 25 1074 1078.
9. Mallofré C, Castillo M, Morente V, Solé M. Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia. Mod. Pathol. 2003 16 187 191.
10. Kunju LP, Lee CT, Montie J, Shah RB. Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia. Pathol. Int. 2005 55 248 254.